Free Trial
NASDAQ:SNGX

Soligenix (SNGX) Stock Price, News & Analysis

Soligenix logo
$3.04 +0.04 (+1.33%)
As of 01:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Soligenix Stock (NASDAQ:SNGX)

Key Stats

Today's Range
$2.99
$3.16
50-Day Range
$1.12
$4.96
52-Week Range
$1.09
$6.23
Volume
212,426 shs
Average Volume
4.34 million shs
Market Capitalization
$13.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Soligenix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

SNGX MarketRank™: 

Soligenix scored higher than 43% of companies evaluated by MarketBeat, and ranked 664th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Soligenix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Soligenix has only been the subject of 1 research reports in the past 90 days.

  • Read more about Soligenix's stock forecast and price target.
  • Earnings Growth

    Earnings for Soligenix are expected to grow in the coming year, from ($4.65) to ($2.93) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Soligenix is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Soligenix is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Soligenix has a P/B Ratio of 6.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Soligenix's valuation and earnings.
  • Percentage of Shares Shorted

    10.40% of the float of Soligenix has been sold short.
  • Short Interest Ratio / Days to Cover

    Soligenix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Soligenix has recently increased by 16.73%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Soligenix does not currently pay a dividend.

  • Dividend Growth

    Soligenix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.40% of the float of Soligenix has been sold short.
  • Short Interest Ratio / Days to Cover

    Soligenix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Soligenix has recently increased by 16.73%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Soligenix has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Soligenix this week, compared to 1 article on an average week.
  • Search Interest

    22 people have searched for SNGX on MarketBeat in the last 30 days. This is an increase of 1,000% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Soligenix to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Soligenix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.05% of the stock of Soligenix is held by insiders.

  • Percentage Held by Institutions

    Only 3.60% of the stock of Soligenix is held by institutions.

  • Read more about Soligenix's insider trading history.
Receive SNGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Soligenix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNGX Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
Small Cap Stocks To Follow Today - August 18th
Soligenix (NASDAQ:SNGX) Cut to Strong Sell at Wall Street Zen
Why Is Soligenix Stock Soaring On Monday?
See More Headlines

SNGX Stock Analysis - Frequently Asked Questions

Soligenix's stock was trading at $2.69 at the start of the year. Since then, SNGX shares have increased by 11.5% and is now trading at $3.00.

Soligenix Inc. (NASDAQ:SNGX) announced its quarterly earnings data on Thursday, August, 14th. The biopharmaceutical company reported ($0.82) EPS for the quarter, missing analysts' consensus estimates of ($0.79) by $0.03.

Soligenix's stock reverse split on Thursday, June 6th 2024.The 1-16 reverse split was announced on Thursday, June 6th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Top institutional investors of Soligenix include Connective Capital Management LLC (3.67%).
View institutional ownership trends
.

Shares of SNGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Soligenix investors own include Tonix Pharmaceuticals (TNXP), Trevena (TRVN), Corbus Pharmaceuticals (CRBP), OPKO Health (OPK), T2 Biosystems (TTOO), iBio (IBIO) and Dynavax Technologies (DVAX).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SNGX
CIK
812796
Employees
20
Year Founded
1987

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+100.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.27 million
Net Margins
N/A
Pretax Margin
-499,900.00%
Return on Equity
-274.76%
Return on Assets
-129.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.47
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$120 thousand
Price / Sales
107.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
6.98

Miscellaneous

Outstanding Shares
4,290,000
Free Float
4,155,000
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.95

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SNGX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners